Medicine News and Research

RSS

Sleep disorders increase health care utilization and costs

Sleep disorders are associated with significantly higher rates of health care utilization, conservatively placing an additional $94.9 billion in costs each year to the United States health care system, according to a new study from researchers at Mass Eye and Ear, a member hospital of Mass General Brigham.

7 May 2021

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.

7 May 2021

Researchers highlight the need for more reliable methods to predict risk of relapse into depression

At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.

7 May 2021

CWHI launches to combat the effects of climate change on vulnerable populations

The Center for Health, Work & Environment at the Colorado School of Public Health and the Colorado Consortium on Climate Change and Human Health have launched the Climate, Work & Health Initiative.

7 May 2021

Absence of key gene causes severe hearing loss

A gene called GAS2 plays a key role in normal hearing, and its absence causes severe hearing loss, according to a study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.

7 May 2021

Using ultrasound and RNA-loaded nanoparticles to deliver potent medicine to brain tumors

RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and able to go where no drug has gone before, reaching previously undruggable pathways.

7 May 2021

CFTR modulator can be safe, well-tolerated for younger children with common form of cystic fibrosis

Children ages two to five who have the most common form of cystic fibrosis (CF), caused by two copies of the F508 gene mutation, have not had any modulator treatments available to them until recently.

7 May 2021

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Today, deliveries via cesarean sections, or c-sections, have become quite common globally. Sometimes, c-sections are a medical necessity when normal deliveries become risky either for the mother or the baby.

7 May 2021

Researchers identify genetic cause of a rare neurological disorder

In a paper published today in Nature Communications, an international group of collaborators led by researchers at UPMC Children's Hospital of Pittsburgh have identified a genetic cause of a rare neurological disorder marked by developmental delay and loss of coordination, or ataxia.

7 May 2021

Laser procedure for pediatric patients with epilepsy holds advantages over traditional brain surgery

Using a laser for a rare brain surgery to treat drop seizures, which cause a child with epilepsy to suddenly fall, holds some advantages over a traditional open craniotomy, including shorter hospital stays for patients, a study led by UT Southwestern researchers indicates.

7 May 2021

Scientists investigate signal necrotic cells that cue phagocytic cells to engulf the dying cell

Just as people keep their houses clean and clutter under control, a crew of cells in the body is in charge of clearing the waste the body generates, including dying cells. The housekeeping cells remove unwanted material by a process called phagocytosis, which literally means 'eating cells.' The housekeepers engulf and ingest the dying cells and break them down to effectively eliminate them.

7 May 2021

Researchers report encouraging results from experimental antiviral targeting Marburg virus

The Marburg virus, a relative of the Ebola virus, causes a serious, often-fatal hemorrhagic fever. Transmitted by the African fruit bat and by direct human-to-human contact, Marburg virus disease currently has no approved vaccine or antivirals to prevent or treat it.

7 May 2021

Researchers describe the key facet of sexual determination in mammalian models

Early in human development, during the first trimester of gestation, a fetus may have XX or XY chromosomes that indicate its sex. Yet at this stage a mass of cells known as the bipotential gonad that ultimately develops into either ovaries or testes has yet to commit to its final destiny.

7 May 2021

Highly efficient immune response in asymptomatic SARS-CoV-2 patients

Researchers in Singapore have investigated the role of SARS-CoV-2-specific antibodies and T-cells in asymptomatic individuals suffering from COVID-19. They found that, contrary to some initial hypotheses, asymptomatic individuals mount an adaptive immune response on par with symptomatic individuals, demonstrating that T cell response does not appear to be correlated with symptom severity.

7 May 2021

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.

7 May 2021

SFHN clinicians support the use of telehealth services for outpatient primary care

As state and federal authorities decide whether to continue reimbursing for telehealth services that were suddenly adopted last spring in response to the coronavirus pandemic, a new study out of UC San Francisco has found that clinicians in the San Francisco Health Network (SFHN) overwhelmingly support using these services for outpatient primary care and specialty care visits.

7 May 2021

Global spread of COVID-19 has raised serious concern for patients with transthyretin amyloidosis

The global spread of COVID-19 has raised serious concern for patients with chronic disease. A correlation has been identified between the severity of COVID-19 and a patient's preexisting comorbidities.

7 May 2021

Professor Cyrus Cooper receives ECTS Steven Boonen Clinical Research award

The International Osteoporosis Foundation is delighted to announce that the European Calcified Tissue Society (ECTS) has presented the prestigious 2021 ECTS Steven Boonen Clinical Research Award to its President, Professor Cyrus Cooper.

7 May 2021

Bubonic plague had long-term impact on human immune genes, indicates study

Scientists examining the remains of 36 bubonic plague victims from a 16th century mass grave in Germany have found the first evidence that evolutionary adaptive processes, driven by the disease, may have conferred immunity on later generations of people from the region.

7 May 2021

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

7 May 2021

Medicine News and Research

Sleep disorders increase health care utilization and costs

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers highlight the need for more reliable methods to predict risk of relapse into depression

CWHI launches to combat the effects of climate change on vulnerable populations

Absence of key gene causes severe hearing loss

Using ultrasound and RNA-loaded nanoparticles to deliver potent medicine to brain tumors

CFTR modulator can be safe, well-tolerated for younger children with common form of cystic fibrosis

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Researchers identify genetic cause of a rare neurological disorder

Laser procedure for pediatric patients with epilepsy holds advantages over traditional brain surgery

Scientists investigate signal necrotic cells that cue phagocytic cells to engulf the dying cell

Researchers report encouraging results from experimental antiviral targeting Marburg virus

Researchers describe the key facet of sexual determination in mammalian models

Highly efficient immune response in asymptomatic SARS-CoV-2 patients

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

SFHN clinicians support the use of telehealth services for outpatient primary care

Global spread of COVID-19 has raised serious concern for patients with transthyretin amyloidosis

Professor Cyrus Cooper receives ECTS Steven Boonen Clinical Research award

Bubonic plague had long-term impact on human immune genes, indicates study

Study may lead to personalized treatments for cystic fibrosis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News